Internal Medicine, Rheumatology · Simpsonville, SC
NPI
1154760601
Since 2013
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
4
Medicare group memberships
Hospitals
5
Hospital affiliations
103 Fairview Pointe Dr
Simpsonville, SC, 29681
Phone (864) 881-8500
Groups this clinician bills Medicare through
Medicare paid, 2024
$51K
4,244 services
Medicare patients, 2024
73
Average age 68
Drug cost, 2024
$7.2M
3,240 prescriptions
Company payments, 2025
$1,424
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Travis C Sizemore was code 99204 (office e&m - new), 27 times for 27 patients. In total Travis C Sizemore billed 4,244 services in 28 codes, and Medicare paid $51K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-10-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99204 Office E&M - New | Office | 27 | 27 | $126.13 | $3,406 |
| 99214 Office E&M - Established | Facility | 20 | 20 | $39.65 | $793 |
| 85652 Clinical Chemistry | Office | 19 | 19 | $2.65 | $50.35 |
| 86200 Immunoassay | Office | 18 | 18 | $12.69 | $228 |
| 86140 Clinical Chemistry | Office | 16 | 16 | $5.08 | $81.28 |
| 80053 Clinical Chemistry | Office | 15 | 15 | $10.35 | $155 |
| 86480 Immunoassay | Office | 15 | 15 | $60.74 | $911 |
| 99214 Office E&M - Established | Office | 14 | 14 | $59.51 | $833 |
| 85025 Blood Count | Office | 11 | 11 | $7.61 | $83.71 |
By year: 2022 $63K for 1,720 services; 2023 $47K for 4,121 services; 2024 $51K for 4,244 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85652 Clinical Chemistry | 19 | 19 | $2.65 | $50.35 |
| 86200 Immunoassay | 18 | 18 | $12.69 | $228 |
| 86140 Clinical Chemistry | 16 | 16 | $5.08 | $81.28 |
| 80053 Clinical Chemistry | 15 | 15 | $10.35 | $155 |
| 86480 Immunoassay | 15 | 15 | $60.74 | $911 |
| 85025 Blood Count | 11 | 11 | $7.61 | $83.71 |
Medicare prescription drug claims, 2024
In 2024, the drug Travis C Sizemore prescribed most often to Medicare patients was Methotrexate (Methotrexate Sodium), with 387 prescriptions and refills. In total Travis C Sizemore wrote 3,240 Medicare prescriptions that cost $7.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Methotrexate Methotrexate Sodium | 387 | 758 | 171 | $7,389 |
| Hydroxychloroquine Sulfate Generic | 369 | 782 | 117 | $10K |
| Prednisone Generic | 317 | 525 | 167 | $1,792 |
| Rinvoq Upadacitinib | 178 | 182 | 27 | $1.1M |
| Humira Pen Adalimumab | 143 | 144 | 24 | $1.0M |
| Humira(Cf) Pen Adalimumab | 110 | 112 | 20 | $861K |
| Enbrel Sureclick Etanercept | 107 | 107 | 17 | $767K |
| Leflunomide Generic | 106 | 176 | 42 | $4,978 |
| Alendronate Sodium Generic | 106 | 188 | 36 | $398 |
| Xeljanz Xr Tofacitinib Citrate | 89 | 89 | 12 | $494K |
| Methylprednisolone Generic | 79 | 79 | 68 | $364 |
| Allopurinol Generic | 60 | 96 | 15 | $266 |
| Folic Acid Generic | 60 | 117 | 16 | $247 |
| Orencia Clickject Abatacept | 57 | 57 | Under 11 | $310K |
| Diclofenac Sodium Generic | 56 | 76 | 25 | $4,538 |
Brand drugs: - claims; generic drugs: 2,081 claims; opioid claims: 51.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Travis C Sizemore $1,424 ($1,424 in general payments such as food, travel and fees) from 17 companies. The largest payer was Amgen Inc. with $216.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 15 | $216 |
| Abbvie Inc. ABBV | 10 | $207 |
| Pfizer Inc. PFE | 13 | $183 |
| Janssen Biotech, Inc. JNJ | 12 | $182 |
| GlaxoSmithKline, LLC. GSK | 4 | $123 |
| E.R. Squibb & Sons, L.L.C. BMY | 3 | $93.79 |
| Mallinckrodt Hospital Products Inc. | 3 | $80.63 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $64.87 |
| Organon LLC OGN | 2 | $45.33 |
| Lilly USA, LLC LLY | 2 | $42.93 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.